Discover 3,590 paid clinical trials in Pasadena, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,590
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
for
Spinal Muscular Atrophy (SMA)
Location: Los Angeles CA, San Diego CA, Madera CA, Phoenix AZ,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 0+
Code: NCT04174157
Recruiting
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
for
Lymphatic Malformations
Location: Orange CA, Palo Alto CA, Oakland CA, Portland OR,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 0 - 70+
Code: NCT05948943
Phase 2, Phase 3, Recruiting
International Rare Histiocytic Disorders Registry (IRHDR)
for
Rare Histiocytic Disorders (RHDs),
Location: Los Angeles CA, Madera CA, Birmingham AL, Pittsburgh PA,
Sponsor: The Hospital for Sick Children
Sex: All
Age: 0+
Code: NCT02285582
Recruiting
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
for
Cancer Pain, Visceral Pain, Gastrointestinal Neoplasms,
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center
Sex: All
Age: 18 - 70+
Code: NCT04907643
Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Los Angeles CA, Duarte CA, Baldwin Park CA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06616584
Phase 2, Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
CAR-T Long Term Follow Up (LTFU) Study
for
Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program,
Location: Los Angeles CA, Duarte CA, Stanford CA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 0 - 70+
Code: NCT02445222
Phase 3, Recruiting
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
for
Dravet Syndrome
Location: Orange CA, Salt Lake City UT, Seattle WA, Vancouver,
Location: Los Angeles CA, West Valley City UT, Portland OR,
Sponsor: MacroGenics
Sex: All
Age: 18+
Code: NCT06242470
Phase 1, Recruiting
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
for
Acral Lentiginous Melanoma,
Location: Burbank CA, Los Angeles CA, San Diego CA, Dublin CA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT04511013
Phase 2, Recruiting
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue
Location: Los Angeles CA, Palo Alto CA, Phoenix AZ,
Sponsor: Nationwide Children's Hospital
Sex: All
Age: 2 - 40
Code: NCT05634369
Phase 1, Phase 2, Recruiting
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
for
Locally Advanced Breast Cancer, Unresectable Breast Carcinoma,
Location: Beverly Hills CA, Newport Beach CA, Vancouver,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06827236
Phase 1, Phase 2, Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: Los Angeles CA, Beverly Hills CA, Torrance CA,
Sponsor: NRG Oncology
Sex: Male
Age: 18+
Code: NCT05946213
Phase 3, Recruiting
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Location: Los Angeles CA, Aurora CO, Calgary, Dallas TX, Edmonton,
Sponsor: Turning Point Therapeutics, Inc.
Sex: All
Age: 0 - 25
Code: NCT04094610
Phase 1, Phase 2, Recruiting
Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma
for
Pituitary Tumor
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center
Sex: All
Age: 18+
Code: NCT00598949
Recruiting
Precise Infliximab Exposure and Pharmacodynamic Control
for
Crohn Disease
Location: Los Angeles CA, San Diego CA, Palo Alto CA,
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 6 - 22
Code: NCT05660746
Phase 2, Phase 3, Recruiting
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
for
Narcolepsy Type 2
Location: Santa Ana CA, Chula Vista CA, Redwood City CA,
Sponsor: Takeda
Sex: All
Age: 18 - 70
Code: NCT06952699
Phase 2, Recruiting
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
for
Metastatic Colorectal Cancer
Location: Los Alamitos CA, Long Beach CA, Chandler AZ, Calgary,
Sponsor: Amgen
Sex: All
Age: 18+
Code: NCT06252649
Phase 3, Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
for
Pyoderma Gangrenosum
Location: Irvine CA, Phoenix AZ, Murray UT, Meridian ID,
Sponsor: LEO Pharma
Sex: All
Age: 18+
Code: NCT06624670
Phase 3, Recruiting
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)